m-35 and Insulin-Resistance

m-35 has been researched along with Insulin-Resistance* in 4 studies

Other Studies

4 other study(ies) available for m-35 and Insulin-Resistance

ArticleYear
Blocking central galanin receptors attenuates insulin sensitivity in myocytes of diabetic trained rats.
    Journal of neuroscience research, 2013, Volume: 91, Issue:7

    Galanin (Gal), a bioactive neuropeptide, is widely distributed throughout the central nervous system and has diverse modulatory effects. To understand the central effect of this training-stimulatory peptide on insulin sensitivity, its antagonist M35 was injected into the cerebral ventricle in type 2 diabetic rats. A treadmill running of the rats was used to stimulate circulating Gal secretion and central Gal mRNA expression. The results showed that M35 significantly decreased glucose infusion rates in euglycemic-hyperinsulinemic clamp tests as well as 2-deoxy-[(3) H]D-glucose uptake and peroxisome proliferator-activated receptor-α expression levels in skeletal muscles. M35 also attenuated glucose transporter 4 (GLUT4) concentration in plasma membranes and total cell membranes of myocytes, and the ratios of the GLUT4 contents in the former to the latter in M35 groups were lower than those of each diabetic control. These results imply that endogenous Gal, acting through its central receptor, may facilitate GLUT4 translocation from cytoplasm vesicles to cellular surface of myocytes to accelerate glucose uptake and to enhance insulin sensitivity in healthy and type 2 diabetic rats. Gal and its relative agents are potential targets for treatment of type 2 diabetes mellitus and its complications.

    Topics: Animals; Bradykinin; Cell Membrane; Deoxyglucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Exercise Test; Galanin; Glucose Transporter Type 4; Insulin Resistance; Locomotion; Male; Muscle Cells; Peptide Fragments; PPAR alpha; Rats; Rats, Wistar; Receptors, Galanin; RNA, Messenger; Streptozocin; Tritium

2013
Exercise-induced galanin release facilitated GLUT4 translocation in adipocytes of type 2 diabetic rats.
    Pharmacology, biochemistry, and behavior, 2012, Volume: 100, Issue:3

    Although galanin has been shown to increase insulin sensitivity in skeletal muscle of rats, there is no literature available about the effect of galanin on Glucose Transporter 4 (GLUT4) translocation from intracellular membrane pools to plasma membranes in adipocytes of type 2 diabetic rats. In the present study M35, a galanin antagonist was used to elucidate whether exercise-induced galanin release increased GLUT4 translocation in adipocytes of streptozotocin-induced diabetic rats. The present findings showed that plasma galanin levels after swimming training in all four trained groups were higher compared with each sedentary control. M35 treatment had an inhibitory effect on glucose infusion rates in the euglycemic-hyperinsulinemic clamp test and GLUT4 mRNA expression levels in adipocytes. Moreover, M35 treatment reduced GLUT4 concentration in both plasma membranes and total cell membranes. The ratios of GLUT4 contents in plasma membranes to total cell membranes in four drug groups were lower compared with each control. These data demonstrate a beneficial role of endogenous galanin to transfer GLUT4 from internal stores to plasma membranes in adipocytes of type 2 diabetic rats. Galanin plays a significant role in regulation of glucose metabolic homeostasis and is an important hormone relative to diabetes.

    Topics: Adipocytes, White; Animals; Bradykinin; Cell Fractionation; Cell Membrane; Diabetes Mellitus, Type 2; Epididymis; Galanin; Gene Expression Regulation; Glucose Transporter Type 4; Insulin Resistance; Male; Motor Activity; Peptide Fragments; Protein Precursors; Protein Transport; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Streptozocin; Swimming

2012
Intracerebroventricular administration of galanin antagonist sustains insulin resistance in adipocytes of type 2 diabetic trained rats.
    Molecular and cellular endocrinology, 2012, Sep-25, Volume: 361, Issue:1-2

    The aim of this study is to investigate whether galanin (GAL) central receptors are involved in regulation of insulin resistance. To test it, a GAL antagonist, M35 was intracerebroventricularly administrated in trained type 2 diabetic rats. The euglycemic-hyperinsulinemic clamp test was conducted for an index of glucose infusion rates. The epididymal fat pads were processed for determination of glucose uptake and Glucose Transporter 4 (GLUT4) amounts. The Gal mRNA expression levels in hypothalamus were quantitatively assessed too. We found an inhibitory effect of M35 on glucose uptake into adipocytes, Gal mRNA expression levels in hypothalamus, glucose infusion rates in the clamp test and GLUT4 concentration in plasma membranes and total cell membranes of adipocytes. The ratios of GLUT4 contents of the former to the latter in M35 groups were lower. These results suggest a facilitating role for GAL on GLUT4 translocation and insulin sensitivity via its central receptors in rats.

    Topics: Adipocytes; Animals; Blood Glucose; Body Weight; Bradykinin; Cell Membrane; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Galanin; Gene Expression Regulation; Glucose Clamp Technique; Glucose Transporter Type 4; Hypothalamus; Injections, Intraventricular; Insulin; Insulin Resistance; Male; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Wistar; RNA, Messenger; Triglycerides

2012
Galanin antagonist increases insulin resistance by reducing glucose transporter 4 effect in adipocytes of rats.
    General and comparative endocrinology, 2011, Aug-01, Volume: 173, Issue:1

    Seeing that galanin increases animal body weight on the conditions of inhibiting insulin secretion and animals with metabolic disorder of galanin easily suffer from diabetes, we postulate that endogenous galanin is necessary to reduce insulin resistance in adipocytes. To test this hypothesis, we compared four groups of rats to examine whether an increase in galanin secretion stimulated by swimming may reduce insulin resistance. The rats from sedentary and trained drug groups were injected by M35, a galanin antagonist. The rats from trained control and trained drug groups swam after each injection for four weeks. We found that exercise significantly elevated plasma galanin contents and glucose transporter 4 (GLUT4) mRNA levels in adipocytes. Meanwhile, M35 treatment reduced GLUT4 and GLUT4 mRNA levels, and glucose infusing rates in euglycemic-hyperinsulinemic clamp tests. The ratios of GLUT4 concentrations at plasma membranes to total cell membranes in both drug groups were lower compared with each control group, respectively. These observations suggest that endogenous galanin reduces insulin resistance by increasing GLUT4 contents and promoting GLUT4 transportation from intracellular membranes to plasma membranes in adipocytes. Galanin is an important hormone to reduce insulin resistance in rats.

    Topics: Adipocytes; Animals; Blotting, Western; Bradykinin; Cell Membrane; Galanin; Glucose Clamp Technique; Glucose Transporter Type 4; Insulin Resistance; Male; Peptide Fragments; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction

2011